I-Corps: Noninvasive detection of bladder cancer using ringing modality of atomic force microscopy

Award ID: 2041813

The broader impact/commercial potential of this I-Corps project is the development of a noninvasive diagnostic test to detect and monitor the presence of bladder cancer and to assess its grade. In the U.S. alone, there are 800,000 survivors living under the fear of a high chance of recurrence (50-80%) from bladder cancer. The majority of the patients require an in-office invasive monitoring procedure repeated every 3 to 6 months. This procedure yields high lifetime costs, pain, and possible complications from trauma to the urethra, which leads to a low patient compliance rate (
NSF Program Director: Ruth Shuman